×
About 6,028 results

ALLMedicine™ Unstable Angina Center

Research & Reviews  1,538 results

Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention...
https://doi.org/10.1016/j.amjcard.2021.11.042
The American Journal of Cardiology; Roumeliotis A, Claessen B et. al.

Jan 16th, 2022 - Cardiovascular disease constitutes the leading cause of mortality worldwide, irrespective of race/ethnicity. Previous studies have shown that minority patients with acute coronary syndrome have distinct clinical, anatomic, and socioeconomic charac...

Long-Term Outcomes for Patients With Acute Coronary Syndrome and Nonvalvular Atrial Fib...
https://doi.org/10.1016/j.amjcard.2021.11.043
The American Journal of Cardiology; Gouda P, Dover DC et. al.

Jan 12th, 2022 - Short-term outcomes are worse for patients with acute coronary syndrome (ACS) with a history of nonvalvular atrial fibrillation (NVAF). However, long-term prognosis remains unclear. We linked administrative health databases to identify patients ho...

Histopathologically confirmed intraplaque haemorrhage in a patient with unstable angina.
https://doi.org/10.1093/ehjci/jeab295
European Heart Journal. Cardiovascular Imaging; Ohashi H, Ando H et. al.

Jan 12th, 2022 - Histopathologically confirmed intraplaque haemorrhage in a patient with unstable angina.|2022|Ohashi H,Ando H,Otsuka F,Takashima H,Amano T,|

Unstable Angina Induced by Fracture of a Recently Implanted Drug-Eluting Stent.
https://www.ncbi.nlm.nih.gov/pubmed/34982729
The Journal of Invasive Cardiology; Soulaidopoulos S, Aznaouridis K et. al.

Jan 5th, 2022 - Stent fracture is a rather infrequent complication associated with in-stent restenosis, thrombosis, aneurysm formation, and ischemic events. Several stent-related parameters, such as the use of longer or multiple stents, stent overlapping, and bal...

see more →

Guidelines  5 results

What's new in antiplatelet and anticoagulant therapy recommendations for unstable angin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652660
Clinical Cardiology; Wenger NK,

Oct 17th, 2012 - This focused update addresses the use of the newly approved oral antiplatelet agents, prasugrel and ticagrelor, for the management of patients with UA/NSTEMI.

2012 Oman Heart Association simplified guidelines for the management of patients with u...
https://doi.org/10.1097/HPC.0b013e31825ac653
Critical Pathways in Cardiology; El-Deeb MH, Al Riyami AM et. al.

Jul 25th, 2012 - Although current practice guidelines provide an evidence-based approach to the management of acute coronary syndromes, application of the evidence by individual physicians has been suboptimal. This gap between comprehensive guidelines and actual p...

2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Mana...
https://doi.org/10.1016/j.jacc.2011.02.011
Journal of the American College of Cardiology; Wright RS, Anderson JL et. al.

May 7th, 2011 - 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Associa...

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Mana...
https://doi.org/10.1161/CIR.0b013e318212bb8b
Circulation Anderson JL, Adams CD et. al.

Mar 30th, 2011 - 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Associa...

Early management of unstable angina and non-ST segment elevation myocardial infarction:...
https://doi.org/10.1136/bmj.c1134
BMJ (Clinical Research Ed.); Crowe E, Lovibond K et. al.

Mar 26th, 2010 - Early management of unstable angina and non-ST segment elevation myocardial infarction: summary of NICE guidance.|2010|Crowe E,Lovibond K,Gray H,Henderson R,Krause T,|therapy,therapeutic use,therapy,diagnosis,therapeutic use,diagnosis,

see more →

Drugs  232 results see all →

Clinicaltrials.gov  120 results

Early Endoscopy for Acute Upper Gastrointestinal Bleeding in Acute Coronary Syndrome Patients
https://clinicaltrials.gov/ct2/show/NCT02618980

Dec 20th, 2021 - MATERIALS AND METHODS Study Design and Randomization A multicenter RCT of recent ACS patients presenting with acute UGIB was conducted in three tertiary centers (Far Eastern Memorial Hospital, Hsin-Chu Branch and Taipei Branch of National Taiwan U...

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
https://clinicaltrials.gov/ct2/show/NCT04695106

Nov 4th, 2021 - Health problem More than 25% of patients referred for diagnostic coronary angiography and percutaneous coronary intervention (PCI) due to acute coronary syndrome (ACS) suffer from non-valvular atrial fibrillation (AF). In this particular setting, ...

Impact of Prediabetes on Acute Coronary Syndrome
https://clinicaltrials.gov/ct2/show/NCT05102851

Nov 2nd, 2021 - Acute Coronary Syndrome refers to a constellation of symptoms compatible with acute myocardial ischemia. The syndrome includes systolic time segment elevation myocardial infarction non-systolic time segment elevation myocardial infarction and unst...

Investigating Fear Of Recurrence as a Modifiable Mechanism of Behavior Change
https://clinicaltrials.gov/ct2/show/NCT03853213

Sep 17th, 2021 - Acute coronary syndrome (ACS; myocardial infarction or unstable angina) is a leading cause of morbidity and mortality in the U.S., with >1 million cases per year. Survivors are at high risk for recurrent cardiovascular disease (CVD) events, partic...

PCSK9 Inhibitor on ACS Patients With Multivessel Disease and Relatively Low LDL-C Level in Chinese Population
https://clinicaltrials.gov/ct2/show/NCT05043740

Sep 14th, 2021 - The study is an open-label, multicenter, and randomized study. The objective of this study is to demonstrate the effect of PCSK9 inhibitor on ACS patients with multivessel disease and relatively low LDL-C levels or LDL-C levels lower than the reco...

see more →

News  511 results

A Natural Winner: Plant-Based Diets and Statins vs Dyslipidemia Risk
https://www.medscape.com/viewarticle/958748

Jan 13th, 2022 - This transcript has been edited for clarity. Laurence Sperling, MD: Welcome to Medscape's InDiscussion series on dyslipidemia. This is episode 5. We'll be discussing nonpharmacologic approaches to cholesterol management. This is a critically impor...

Hypertension With Right Subclavian Plaque Tied to CV Events
https://www.medscape.com/viewarticle/965796

Dec 30th, 2021 - The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaways The study demonstrates that the prevalence of right subclavian plaques is an independent risk factor for future c...

Cardiovascular Benefits of DPP-4i Vs Sulphonylureas as Add-on to Metformin in T2D Patients
https://www.medscape.com/viewarticle/965554

Dec 23rd, 2021 - Takeaway In patients with type 2 diabetes (T2D) with and without major adverse cardiovascular events (MACE), those who initiated dipeptidyl-peptidase-4 inhibitors (DPP-4i) as an add-on treatment to metformin had a similar risk of MACE compared wit...

Darolutamide Plus Docetaxel/ADT Significantly Improves OS in Metastatic Hormone-Sensitive Prostate Cancer
https://www.onclive.com/view/darolutamide-plus-docetaxel-adt-significantly-improves-os-in-metastatic-hormone-sensitive-prostate-cancer

Dec 3rd, 2021 - The addition of darolutamide (Nubeqa) to docetaxel and androgen deprivation therapy (ADT) resulted in a significant improvement in overall survival (OS) compared with docetaxel/ADT alone in patients with metastatic hormone-sensitive prostate cance...

Tampa General Hospital, Florida Cancer Specialists, Proton Therapy Partners and Florida Urology Partners Come Together with Plans to Open the Region’s First Proton Therapy Center
https://www.onclive.com/view/tampa-general-hospital-florida-cancer-specialists-proton-therapy-partners-and-florida-urology-partners-come-together-with-plans-to-open-the-region-s-first-proton-therapy-center

Nov 18th, 2021 - Tampa General Hospital (TGH), the Florida Cancer Specialists & Research Institute (FCS), Proton Therapy Partners and Florida Urology Partners announced a new collaborative partnership with plans to build a proton therapy center in Tampa Bay that w...

see more →

Patient Education  5 results see all →